| Value | ₹2.81 Cr |
|---|
NSE filing, NSE: AGUL. Summary written from the filing by ALFA Finder's alert engine.
A G Universal Ltd: key numbers
- Share price
- ₹51.75
- Market cap
- ₹28.38 Cr
- Revenue (annual)
- ₹73.48 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- 336.6×Sector 16.5×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from A G Universal Ltd
All →A G Universal Management Change
AG Universal's statutory auditor, Goyal Nagpal & Co., resigned effective 29 October 2026, citing staffing constraints. A replacement auditor must now be appointed.
A G Universal Annual General Meeting
AG Universal Limited held its 18th AGM on September 30, 2026. Shareholders considered resolutions including a 20,00,000 warrant issuance and the sale of its Jhajjar manufacturing unit.
A G Universal Annual General Meeting
A G Universal Limited will hold its 18th Annual General Meeting on September 30, 2026. The company has also filed its Annual Report for 2025-26.
A G Universal Board Meeting Outcome
A G Universal approved its Annual Report, scheduled the AGM for September 30, 2026, and authorized the disposal of its manufacturing unit in Jhajjar, Haryana.
A G Universal Board Meeting Date
A G Universal Limited has scheduled a Board Meeting for September 5, 2026. The meeting agenda is limited to considering other business matters.
A G Universal Management Change
Mr. Atul Mahajan has resigned as a Non-Executive Independent Director of A G Universal Limited, effective from the close of business hours on September 30, 2026.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.